Ignite Creation Date:
2024-05-05 @ 11:55 AM
Last Modification Date:
2024-10-26 @ 9:16 AM
Study NCT ID:
NCT00171561
Status:
COMPLETED
Last Update Posted:
2011-11-08
First Post:
2005-09-12
Brief Title:
ValsartanHydrochlorothiazide Combination vs Amlodipine in Patients With Hypertension Diabetes and Albuminuria
Sponsor:
Novartis
Organization:
Novartis
Study Overview
Official Title:
A 24-week Study to Evaluate the Effectiveness of Valsartan in Combination With Hydrochlorothiazide Versus Amlodipine on Arterial Compliance in Patients With Hypertension Type 2 Diabetes and Albuminuria
Status:
COMPLETED
Status Verified Date:
2011-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is assess if treatment with valsartan and a diuretic hydrochlorothiazide has beneficial effects in people with high blood pressure diabetes and albuminuria protein in the urine compared with amlodipine In particular the study will assess whether the treatment will decrease the stiffness of the blood vessels
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None